Researchers at the University of Cambridge have published a landmark study in the Proceedings of the National Academy of Sciences…
Read More
International Research Team Discovers First Isospin-Symmetric Island of Inversion in Molybdenum-84
In a landmark discovery that challenges decades of established nuclear theory, an international collaboration of physicists has identified a new…
Read More
Johnson & Johnson’s Icotyde Poised to Challenge AbbVie’s Skyrizi in Plaque Psoriasis Market
The landscape of plaque psoriasis treatment is on the cusp of a significant shift with the U.S. Food and Drug…
Read More
Project Hail Mary: A Scientific Scrutiny of Andy Weir’s Interstellar Rescue Mission
Two science journalists, molecular biology reporter Tina Hesman Saey and climate and earth science writer Carolyn Gramling, ventured into a…
Read More
Unveiling the Ancient Blueprint: Ctenophore Sensory Organ Reveals Unexpected Neural Complexity and Early Brain-Like Systems
Bergen, Norway – A groundbreaking study employing advanced three-dimensional reconstruction techniques has revealed an astonishing level of structural and functional…
Read More
Japanese Researchers Uncover Protein Interaction Essential for Sperm Development and Male Fertility
A multi-institutional research team led by Osaka University has identified a critical protein-to-protein interaction that serves as a master regulator…
Read More
FDA refuses to review Moderna’s mRNA flu vaccine
Moderna, a leading biotechnology company known for its pioneering work in mRNA technology, has been dealt a significant setback by…
Read More
Nitric Oxide-Mediated Modification of TSC2 Protein Identified as Key Driver in Autism Spectrum Disorder Pathogenesis
A landmark study published in Molecular Psychiatry has unveiled a specific biochemical pathway that may explain the underlying neurobiology of…
Read More
Engineers make magnets behave like graphene
The pursuit of next-generation electronic devices has long been bifurcated into two primary fields of study: the movement of charge…
Read More
Congruence secures $39.5m to advance small molecule correctors pipeline
Congruence Therapeutics, a pioneering biotechnology company focused on developing novel small molecule correctors, has successfully closed a significant $39.5 million…
Read More
